Imine reductase
 | This article, Imine reductase, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
Comment: Notable per https://pubs.acs.org/doi/10.1021/jacs.2c11354 and well sourced, thank you Ozzie10aaaa (talk) 15:31, 28 January 2024 (UTC)
An imine reductase (IRED) is an enzyme that selectively reduces imines over ketones or aldehydes.[1][2] This selectivity has allowed this family of enzymes to be employed in stereoselective reductive amination processes for the industrial production of amine-containing pharmaceuticals.[3] Reductive aminations are a two-step chemical reaction where a ketone and amine pair are first joined via imine formation and second reduced to the corresponding amine. IRED enzymes that are found to catalyze both imine formation and imine reduction are called reductive aminases (RedAms).
Function
Imine reduction
Originally discovered in 2010 by screening bacterial strains for reducing activity on 2-methyl-1-pyrroline (2-MPN).[4][5] Based on each member's ability to reduce 2-MPN to (R)- or (S)-2-methylpyrrolidine they are designated as R-selective or S-selective, respectively.[6][7]
Reductive amination
IREDs have been employed to reduce imines spontaneously formed from ketone-amine mixtures.[1][2] This is not a genuine reductive amination catalyst as only the second half of the two-part reaction is catalyzed. In 2017 an IRED was discovered that catalyzed both steps of reductive amination of a wide scope of ketone-amine pairs.[8] These are dubbed reductive aminases (RedAms).[1][2] Engineered RedAms have been employed in industrial processes to support production of pharmaceuticals for clinical trials and commercial manufacturing.[9][10]
Structure
IREDs are dimeric enzymes with each protomer having an N-terminal Rossmann nucleotide-binding domain and a C-terminal dimerization domain.[11]
See also
References
- ^ a b c Mangas-Sanchez, Juan; France, Scott P; Montgomery, Sarah L; Aleku, Godwin A; Man, Henry; Sharma, Mahima; Ramsden, Jeremy I; Grogan, Gideon; Turner, Nicholas J (2017). "Imine reductases (IREDs)". Current Opinion in Chemical Biology. 37: 19–25. doi:10.1016/j.cbpa.2016.11.022. PMID 28038349.
- ^ a b c Lenz, Maike; Borlinghaus, Niels; Weinmann, Leonie; Nestl, Bettina M. (2017). "Recent advances in imine reductase-catalyzed reactions". World Journal of Microbiology and Biotechnology. 33 (11): 199. doi:10.1007/s11274-017-2365-8. ISSN 0959-3993. PMID 29022156. S2CID 255141416.
- ^ Gilio, Amelia K.; Thorpe, Thomas W.; Turner, Nicholas; Grogan, Gideon (2022). "Reductive aminations by imine reductases: from milligrams to tons". Chemical Science. 13 (17): 4697–4713. doi:10.1039/D2SC00124A. ISSN 2041-6520. PMC 9067572. PMID 35655886.
- ^ Mitsukura, Koichi; Suzuki, Mai; Tada, Kazuhiro; Yoshida, Toyokazu; Nagasawa, Toru (2010-08-12). "Asymmetric synthesis of chiral cyclic amine from cyclic imine by bacterial whole-cell catalyst of enantioselective imine reductase". Organic & Biomolecular Chemistry. 8 (20): 4533–4535. doi:10.1039/C0OB00353K. ISSN 1477-0520. PMID 20820664.
- ^ Mitsukura, Koichi; Suzuki, Mai; Shinoda, Sho; Kuramoto, Tatsuya; Yoshida, Toyokazu; Nagasawa, Toru (2011-09-23). "Purification and Characterization of a Novel ( R )-Imine Reductase from Streptomyces sp. GF3587". Bioscience, Biotechnology, and Biochemistry. 75 (9): 1778–1782. doi:10.1271/bbb.110303. ISSN 0916-8451. PMID 21897027.
- ^ Scheller, Philipp N.; Fademrecht, Silvia; Hofelzer, Sebastian; Pleiss, Jürgen; Leipold, Friedemann; Turner, Nicholas J.; Nestl, Bettina M.; Hauer, Bernhard (2014-10-13). "Enzyme Toolbox: Novel Enantiocomplementary Imine Reductases". ChemBioChem. 15 (15): 2201–2204. doi:10.1002/cbic.201402213. ISSN 1439-4227. PMID 25163890. S2CID 42316871.
- ^ Fademrecht, Silvia; Scheller, Philipp N.; Nestl, Bettina M.; Hauer, Bernhard; Pleiss, Jürgen (2016). "Identification of imine reductase-specific sequence motifs". Proteins: Structure, Function, and Bioinformatics. 84 (5): 600–610. doi:10.1002/prot.25008. ISSN 0887-3585. PMID 26857686. S2CID 10149699.
- ^ Aleku, Godwin A.; France, Scott P.; Man, Henry; Mangas-Sanchez, Juan; Montgomery, Sarah L.; Sharma, Mahima; Leipold, Friedemann; Hussain, Shahed; Grogan, Gideon; Turner, Nicholas J. (2017). "A reductive aminase from Aspergillus oryzae". Nature Chemistry. 9 (10): 961–969. Bibcode:2017NatCh...9..961A. doi:10.1038/nchem.2782. ISSN 1755-4330. PMID 28937665. S2CID 33498137.
- ^ Schober, Markus; MacDermaid, Chris; Ollis, Anne A.; Chang, Sandy; Khan, Diluar; Hosford, Joseph; Latham, Jonathan; Ihnken, Leigh Anne F.; Brown, Murray J. B.; Fuerst, Douglas; Sanganee, Mahesh J.; Roiban, Gheorghe-Doru (2019-09-16). "Chiral synthesis of LSD1 inhibitor GSK2879552 enabled by directed evolution of an imine reductase". Nature Catalysis. 2 (10): 909–915. doi:10.1038/s41929-019-0341-4. ISSN 2520-1158. S2CID 202580808.
- ^ Kumar, Rajesh; Karmilowicz, Michael J.; Burke, Dylan; Burns, Michael P.; Clark, Leslie A.; Connor, Christina G.; Cordi, Eric; Do, Nga M.; Doyle, Kevin M.; Hoagland, Steve; Lewis, Chad A.; Mangan, David; Martinez, Carlos A.; McInturff, Emma L.; Meldrum, Kevin (2021-09-21). "Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor". Nature Catalysis. 4 (9): 775–782. doi:10.1038/s41929-021-00671-5. ISSN 2520-1158. S2CID 237588372.
- ^ Rodríguez-Mata, María; Frank, Annika; Wells, Elizabeth; Leipold, Friedemann; Turner, Nicholas J.; Hart, Sam; Turkenburg, Johan P.; Grogan, Gideon (2013-07-22). "Structure and Activity of NADPH-Dependent Reductase Q1EQE0 from Streptomyces kanamyceticus , which Catalyses the R -Selective Reduction of an Imine Substrate". ChemBioChem. 14 (11): 1372–1379. doi:10.1002/cbic.201300321. ISSN 1439-4227. PMID 23813853. S2CID 205557837.